vs
KESTRA MEDICAL TECHNOLOGIES, LTD.（KMTS）与Simulations Plus, Inc.（SLP）财务数据对比。点击上方公司名可切换其他公司
KESTRA MEDICAL TECHNOLOGIES, LTD.的季度营收约是Simulations Plus, Inc.的1.2倍（$22.6M vs $18.4M），Simulations Plus, Inc.净利率更高（3.7% vs -145.3%，领先149.0%）
Kestra Medical Technologies（KMTS）是一家专注于微创医疗器械研发、生产与商业化的医疗科技企业，核心产品覆盖介入心脏病学与结构性心脏病治疗领域，市场覆盖北美、欧洲及亚太重点区域，服务全球医疗机构与患者。
Simulations Plus公司为医药生物、化工、化妆品、食品原料及除草剂领域开发ADMET（吸收、分布、代谢、排泄和毒性）建模仿真软件，并于2014年9月收购了提供临床试验数据分析及咨询服务的Cognigen公司，助力相关行业研发工作开展。
KMTS vs SLP — 直观对比
营收规模更大
KMTS
是对方的1.2倍
$18.4M
净利率更高
SLP
高出149.0%
-145.3%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $22.6M | $18.4M |
| 净利润 | $-32.8M | $676.0K |
| 毛利率 | 50.6% | 59.1% |
| 营业利润率 | -140.7% | 3.9% |
| 净利率 | -145.3% | 3.7% |
| 营收同比 | — | -2.7% |
| 净利润同比 | — | 228.2% |
| 每股收益（稀释后） | $-0.64 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KMTSSLP
| Q4 25 | $22.6M | $18.4M | ||
| Q3 25 | $19.4M | $17.5M | ||
| Q2 25 | — | $20.4M | ||
| Q1 25 | — | $22.4M | ||
| Q4 24 | — | $18.9M | ||
| Q3 24 | — | $18.7M | ||
| Q2 24 | — | $18.5M | ||
| Q1 24 | — | $18.3M |
净利润KMTSSLP
| Q4 25 | $-32.8M | $676.0K | ||
| Q3 25 | $-25.8M | $-681.0K | ||
| Q2 25 | — | $-67.3M | ||
| Q1 25 | — | $3.1M | ||
| Q4 24 | — | $206.0K | ||
| Q3 24 | — | $843.0K | ||
| Q2 24 | — | $3.1M | ||
| Q1 24 | — | $4.0M |
毛利率KMTSSLP
| Q4 25 | 50.6% | 59.1% | ||
| Q3 25 | 45.7% | 56.4% | ||
| Q2 25 | — | 64.0% | ||
| Q1 25 | — | 58.5% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 71.5% | ||
| Q1 24 | — | 72.2% |
营业利润率KMTSSLP
| Q4 25 | -140.7% | 3.9% | ||
| Q3 25 | -149.1% | 3.8% | ||
| Q2 25 | — | -364.5% | ||
| Q1 25 | — | 12.1% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | -6.2% | ||
| Q2 24 | — | 10.1% | ||
| Q1 24 | — | 24.3% |
净利率KMTSSLP
| Q4 25 | -145.3% | 3.7% | ||
| Q3 25 | -133.3% | -3.9% | ||
| Q2 25 | — | -330.6% | ||
| Q1 25 | — | 13.7% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 16.9% | ||
| Q1 24 | — | 22.0% |
每股收益（稀释后）KMTSSLP
| Q4 25 | $-0.64 | $0.03 | ||
| Q3 25 | $-0.50 | $-0.03 | ||
| Q2 25 | — | $-3.35 | ||
| Q1 25 | — | $0.15 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $0.15 | ||
| Q1 24 | — | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $175.4M | $35.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $164.1M | $127.1M |
| 总资产 | $246.7M | $137.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KMTSSLP
| Q4 25 | $175.4M | $35.7M | ||
| Q3 25 | $201.2M | $32.4M | ||
| Q2 25 | — | $28.4M | ||
| Q1 25 | — | $21.4M | ||
| Q4 24 | — | $18.2M | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | — | $119.0M | ||
| Q1 24 | — | $108.5M |
股东权益KMTSSLP
| Q4 25 | $164.1M | $127.1M | ||
| Q3 25 | $184.2M | $124.8M | ||
| Q2 25 | — | $123.8M | ||
| Q1 25 | — | $189.5M | ||
| Q4 24 | — | $184.7M | ||
| Q3 24 | — | $182.4M | ||
| Q2 24 | — | $180.9M | ||
| Q1 24 | — | $177.0M |
总资产KMTSSLP
| Q4 25 | $246.7M | $137.8M | ||
| Q3 25 | $266.3M | $131.9M | ||
| Q2 25 | — | $134.4M | ||
| Q1 25 | — | $201.4M | ||
| Q4 24 | — | $196.9M | ||
| Q3 24 | — | $196.6M | ||
| Q2 24 | — | $192.7M | ||
| Q1 24 | — | $194.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.3M | $4.2M |
| 自由现金流经营现金流 - 资本支出 | $-25.6M | — |
| 自由现金流率自由现金流/营收 | -113.5% | — |
| 资本支出强度资本支出/营收 | 32.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 6.26× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流KMTSSLP
| Q4 25 | $-18.3M | $4.2M | ||
| Q3 25 | $-26.3M | $5.6M | ||
| Q2 25 | — | $8.1M | ||
| Q1 25 | — | $5.7M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $5.7M | ||
| Q1 24 | — | $5.8M |
自由现金流KMTSSLP
| Q4 25 | $-25.6M | — | ||
| Q3 25 | $-34.4M | $5.3M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | — | $-1.4M | ||
| Q3 24 | — | $1.6M | ||
| Q2 24 | — | $5.6M | ||
| Q1 24 | — | $5.4M |
自由现金流率KMTSSLP
| Q4 25 | -113.5% | — | ||
| Q3 25 | -177.8% | 30.5% | ||
| Q2 25 | — | 38.5% | ||
| Q1 25 | — | 25.0% | ||
| Q4 24 | — | -7.2% | ||
| Q3 24 | — | 8.8% | ||
| Q2 24 | — | 30.0% | ||
| Q1 24 | — | 29.4% |
资本支出强度KMTSSLP
| Q4 25 | 32.2% | 0.0% | ||
| Q3 25 | 42.2% | 1.5% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 2.4% |
现金转化率KMTSSLP
| Q4 25 | — | 6.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.84× | ||
| Q4 24 | — | -6.18× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 1.81× | ||
| Q1 24 | — | 1.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KMTS
暂无分部数据
SLP
| Services Segment | $9.5M | 52% |
| Development | $7.2M | 39% |
| Discovery | $1.3M | 7% |
